20 results
DEF 14A
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Definitive proxy
8:24am
, a hematology and oncology company focused on innovative medicines for patients in the Asia Pacific Region and worldwide. Prior to Antengene, Ms
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
retail consumers. Our product pipeline also includes innovative regenerative bone and tissue healing products that are under development.
Business … the demanding technical requirements of professional care providers and discerning retail consumers. Our product pipeline also includes innovative regenerative
8-K
EX-99.1
yg380mpqtbee90
16 Jan 24
Carmell Corp Announces Addition of Dr. Bradley Calobrace to Scientific Advisory Board
7:27pm
8-K
EX-99.1
dz5wwxn
15 Nov 23
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
9:54pm
425
qoym m4la1hr
6 Jul 23
Business combination disclosure
5:15pm
8-K
EX-99.1
0a2 v96fab
6 Jul 23
Other Events
5:11pm
10-K
4rr9r1e6dsrgxl8hyh
15 Apr 22
Annual report
5:11pm
424B4
1agoo1816 9kjlw
27 Jul 21
Prospectus supplement with pricing info
10:42am
S-1
8fqqful
4 Mar 21
IPO registration
4:01pm
- Prev
- 1
- Next